Paul Rozance
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 74 | 2025 | 855 | 7.800 |
Why?
| | Hypoglycemia | 29 | 2024 | 443 | 7.340 |
Why?
| | Glucose | 47 | 2024 | 1018 | 7.210 |
Why?
| | Fetus | 47 | 2025 | 807 | 7.010 |
Why?
| | Fetal Growth Retardation | 54 | 2024 | 565 | 6.920 |
Why?
| | Insulin | 45 | 2025 | 2398 | 5.350 |
Why?
| | Placental Insufficiency | 21 | 2024 | 116 | 4.960 |
Why?
| | Amino Acids | 20 | 2025 | 503 | 3.730 |
Why?
| | Blood Glucose | 34 | 2025 | 2183 | 3.700 |
Why?
| | Islets of Langerhans | 13 | 2024 | 803 | 3.490 |
Why?
| | Insulin-Secreting Cells | 14 | 2024 | 372 | 3.430 |
Why?
| | Pregnancy | 89 | 2025 | 6745 | 3.060 |
Why?
| | Insulin-Like Growth Factor I | 9 | 2024 | 316 | 3.060 |
Why?
| | Placenta | 16 | 2025 | 754 | 2.830 |
Why?
| | Glucagon | 10 | 2025 | 109 | 2.720 |
Why?
| | Liver | 20 | 2025 | 1940 | 2.500 |
Why?
| | Fetal Development | 17 | 2024 | 296 | 2.490 |
Why?
| | Pancreas | 14 | 2024 | 328 | 2.270 |
Why?
| | Hyperinsulinism | 7 | 2020 | 121 | 2.090 |
Why?
| | Leucine | 8 | 2022 | 111 | 2.030 |
Why?
| | Hyperglycemia | 7 | 2021 | 346 | 1.940 |
Why?
| | Infant, Premature | 8 | 2024 | 568 | 1.750 |
Why?
| | Infant, Newborn, Diseases | 5 | 2019 | 113 | 1.740 |
Why?
| | Maternal-Fetal Exchange | 7 | 2024 | 165 | 1.560 |
Why?
| | Animals | 87 | 2025 | 37011 | 1.500 |
Why?
| | Fetal Blood | 10 | 2024 | 327 | 1.370 |
Why?
| | Muscle, Skeletal | 15 | 2022 | 1701 | 1.330 |
Why?
| | Myoblasts | 3 | 2021 | 84 | 1.310 |
Why?
| | Infant, Newborn | 25 | 2024 | 6059 | 1.270 |
Why?
| | Female | 100 | 2025 | 73162 | 1.240 |
Why?
| | Monitoring, Physiologic | 3 | 2018 | 267 | 1.180 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2024 | 252 | 1.170 |
Why?
| | Fetal Hypoxia | 3 | 2021 | 54 | 1.170 |
Why?
| | Hypoxia | 6 | 2021 | 1108 | 1.170 |
Why?
| | Cell Proliferation | 6 | 2024 | 2482 | 1.160 |
Why?
| | Gestational Age | 14 | 2021 | 903 | 1.130 |
Why?
| | Gluconeogenesis | 8 | 2025 | 79 | 1.000 |
Why?
| | Placental Lactogen | 6 | 2024 | 23 | 0.990 |
Why?
| | Glucagon-Secreting Cells | 2 | 2024 | 24 | 0.990 |
Why?
| | Hepatocyte Growth Factor | 2 | 2016 | 35 | 0.950 |
Why?
| | Hypoglycemic Agents | 7 | 2024 | 1285 | 0.840 |
Why?
| | Metformin | 2 | 2024 | 328 | 0.830 |
Why?
| | Diabetes, Gestational | 3 | 2022 | 316 | 0.780 |
Why?
| | Hindlimb | 3 | 2021 | 128 | 0.750 |
Why?
| | Streptozocin | 1 | 2021 | 21 | 0.720 |
Why?
| | Muscle Proteins | 3 | 2022 | 229 | 0.710 |
Why?
| | Signal Transduction | 9 | 2021 | 5096 | 0.700 |
Why?
| | NF-kappa B | 2 | 2021 | 694 | 0.670 |
Why?
| | Caloric Restriction | 2 | 2024 | 121 | 0.660 |
Why?
| | Oxygen | 13 | 2024 | 943 | 0.640 |
Why?
| | RNA Interference | 5 | 2024 | 464 | 0.610 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2018 | 68 | 0.580 |
Why?
| | Anemia | 2 | 2017 | 171 | 0.570 |
Why?
| | Catecholamines | 2 | 2017 | 98 | 0.550 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 3 | 2016 | 32 | 0.550 |
Why?
| | Surface-Active Agents | 1 | 2017 | 92 | 0.530 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.510 |
Why?
| | Respiratory System | 1 | 2017 | 158 | 0.510 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2016 | 54 | 0.500 |
Why?
| | Protein Biosynthesis | 3 | 2017 | 434 | 0.500 |
Why?
| | Drug Administration Schedule | 4 | 2021 | 784 | 0.490 |
Why?
| | Oxidation-Reduction | 8 | 2024 | 1059 | 0.490 |
Why?
| | Developmental Disabilities | 2 | 2015 | 266 | 0.490 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2021 | 640 | 0.480 |
Why?
| | Sweetening Agents | 1 | 2015 | 53 | 0.480 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2016 | 544 | 0.480 |
Why?
| | RNA, Messenger | 7 | 2022 | 2838 | 0.480 |
Why?
| | Infant, Small for Gestational Age | 2 | 2018 | 92 | 0.470 |
Why?
| | Lactic Acid | 8 | 2024 | 306 | 0.470 |
Why?
| | Postpartum Period | 1 | 2018 | 341 | 0.470 |
Why?
| | Diazoxide | 3 | 2024 | 22 | 0.460 |
Why?
| | Humans | 45 | 2024 | 137514 | 0.440 |
Why?
| | Disease Models, Animal | 15 | 2024 | 4295 | 0.440 |
Why?
| | Uterus | 5 | 2022 | 215 | 0.440 |
Why?
| | Acidosis | 2 | 2020 | 101 | 0.430 |
Why?
| | Pregnancy Complications | 3 | 2019 | 521 | 0.430 |
Why?
| | Placental Circulation | 3 | 2021 | 70 | 0.420 |
Why?
| | Endothelial Cells | 3 | 2018 | 780 | 0.420 |
Why?
| | Hepatocytes | 5 | 2024 | 220 | 0.390 |
Why?
| | Periodicals as Topic | 2 | 2017 | 211 | 0.390 |
Why?
| | Stress, Physiological | 1 | 2016 | 445 | 0.390 |
Why?
| | Glucose Clamp Technique | 5 | 2020 | 194 | 0.390 |
Why?
| | Organ Size | 7 | 2021 | 479 | 0.380 |
Why?
| | Random Allocation | 7 | 2012 | 357 | 0.380 |
Why?
| | Muscle Development | 3 | 2021 | 111 | 0.370 |
Why?
| | Malnutrition | 1 | 2012 | 82 | 0.370 |
Why?
| | Diabetes Mellitus, Type 2 | 6 | 2024 | 2521 | 0.340 |
Why?
| | Male | 27 | 2024 | 67718 | 0.340 |
Why?
| | Pulmonary Artery | 2 | 2018 | 1083 | 0.330 |
Why?
| | Dietary Supplements | 3 | 2012 | 563 | 0.330 |
Why?
| | Insulins | 2 | 2022 | 37 | 0.330 |
Why?
| | Dietary Proteins | 1 | 2011 | 135 | 0.320 |
Why?
| | Insulin Resistance | 7 | 2019 | 1198 | 0.310 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 16 | 0.310 |
Why?
| | Pulmonary Alveoli | 1 | 2011 | 405 | 0.300 |
Why?
| | Infant | 9 | 2023 | 9467 | 0.290 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2007 | 145 | 0.280 |
Why?
| | Fetal Diseases | 3 | 2021 | 172 | 0.280 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 216 | 0.280 |
Why?
| | Gene Expression Regulation | 6 | 2021 | 2615 | 0.270 |
Why?
| | Infusion Pumps | 2 | 2021 | 32 | 0.260 |
Why?
| | Fetal Macrosomia | 2 | 2021 | 62 | 0.260 |
Why?
| | Down-Regulation | 3 | 2017 | 658 | 0.260 |
Why?
| | Amino Acids, Essential | 1 | 2006 | 13 | 0.250 |
Why?
| | Up-Regulation | 4 | 2017 | 846 | 0.250 |
Why?
| | History, 20th Century | 3 | 2017 | 324 | 0.240 |
Why?
| | Glucose-6-Phosphatase | 4 | 2016 | 33 | 0.240 |
Why?
| | Infusions, Intravenous | 5 | 2024 | 411 | 0.240 |
Why?
| | Sheep, Domestic | 6 | 2019 | 34 | 0.230 |
Why?
| | Receptors, Glucagon | 1 | 2025 | 28 | 0.230 |
Why?
| | Breast Feeding | 2 | 2019 | 439 | 0.230 |
Why?
| | Pediatrics | 5 | 2018 | 1123 | 0.220 |
Why?
| | Neonatologists | 1 | 2024 | 7 | 0.220 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2024 | 608 | 0.220 |
Why?
| | Fetal Heart | 1 | 2024 | 55 | 0.210 |
Why?
| | Mitochondria, Heart | 1 | 2024 | 100 | 0.210 |
Why?
| | Lipid Metabolism | 3 | 2024 | 511 | 0.210 |
Why?
| | Norepinephrine | 4 | 2020 | 212 | 0.200 |
Why?
| | Adaptation, Physiological | 2 | 2021 | 546 | 0.200 |
Why?
| | Arginine | 4 | 2012 | 274 | 0.200 |
Why?
| | Chronic Disease | 4 | 2017 | 1790 | 0.200 |
Why?
| | Nervous System Diseases | 1 | 2006 | 265 | 0.200 |
Why?
| | Hydrocortisone | 5 | 2020 | 318 | 0.200 |
Why?
| | Carbohydrates | 1 | 2022 | 67 | 0.200 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2020 | 22 | 0.190 |
Why?
| | Fetal Weight | 3 | 2022 | 56 | 0.190 |
Why?
| | Diet, High-Fat | 2 | 2023 | 248 | 0.190 |
Why?
| | Glycogen | 3 | 2020 | 55 | 0.190 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 12 | 0.190 |
Why?
| | Insulinoma | 1 | 2021 | 27 | 0.180 |
Why?
| | Oxygen Consumption | 2 | 2024 | 684 | 0.180 |
Why?
| | Feces | 1 | 2024 | 479 | 0.180 |
Why?
| | Carotid Arteries | 2 | 2013 | 206 | 0.180 |
Why?
| | I-kappa B Kinase | 1 | 2021 | 55 | 0.180 |
Why?
| | Chemokine CXCL10 | 1 | 2021 | 39 | 0.180 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2021 | 173 | 0.170 |
Why?
| | Endotoxemia | 1 | 2021 | 86 | 0.170 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 72 | 0.170 |
Why?
| | Biosensing Techniques | 2 | 2014 | 127 | 0.170 |
Why?
| | Mitochondria, Liver | 1 | 2020 | 74 | 0.170 |
Why?
| | Gene Silencing | 1 | 2021 | 195 | 0.170 |
Why?
| | Transcriptome | 2 | 2024 | 974 | 0.160 |
Why?
| | Chorioamnionitis | 1 | 2020 | 42 | 0.160 |
Why?
| | Energy Intake | 1 | 2022 | 478 | 0.160 |
Why?
| | Drug Synergism | 1 | 2020 | 379 | 0.160 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2021 | 194 | 0.160 |
Why?
| | Receptor, Insulin | 2 | 2011 | 105 | 0.160 |
Why?
| | Transcription Factors | 1 | 2007 | 1717 | 0.160 |
Why?
| | Extracellular Matrix | 2 | 2013 | 528 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2019 | 175 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 974 | 0.150 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2018 | 26 | 0.150 |
Why?
| | Phosphorylation | 3 | 2019 | 1762 | 0.140 |
Why?
| | Vascular Stiffness | 2 | 2013 | 492 | 0.140 |
Why?
| | Transcription Factor RelA | 1 | 2018 | 88 | 0.140 |
Why?
| | Cell Survival | 1 | 2021 | 1122 | 0.140 |
Why?
| | Cell Count | 1 | 2018 | 321 | 0.140 |
Why?
| | Umbilical Cord | 2 | 2016 | 85 | 0.140 |
Why?
| | Neonatology | 1 | 2018 | 29 | 0.140 |
Why?
| | Infant, Extremely Premature | 1 | 2018 | 66 | 0.140 |
Why?
| | Adipose Tissue | 1 | 2021 | 624 | 0.140 |
Why?
| | Overnutrition | 1 | 2017 | 30 | 0.140 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2024 | 856 | 0.130 |
Why?
| | Infant Formula | 1 | 2017 | 75 | 0.130 |
Why?
| | Enteral Nutrition | 1 | 2019 | 200 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2019 | 437 | 0.130 |
Why?
| | Energy Metabolism | 2 | 2021 | 895 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 1 | 2024 | 696 | 0.130 |
Why?
| | Time Factors | 4 | 2012 | 6817 | 0.130 |
Why?
| | Arteries | 1 | 2018 | 269 | 0.130 |
Why?
| | Hemodynamics | 1 | 2021 | 1114 | 0.130 |
Why?
| | Calcium | 1 | 2022 | 1233 | 0.120 |
Why?
| | Blotting, Western | 4 | 2019 | 1227 | 0.120 |
Why?
| | Potassium Chloride | 2 | 2014 | 40 | 0.120 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1242 | 0.120 |
Why?
| | Treatment Failure | 1 | 2017 | 353 | 0.120 |
Why?
| | Ultrasonography, Prenatal | 1 | 2018 | 284 | 0.120 |
Why?
| | Linear Models | 1 | 2018 | 851 | 0.120 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2012 | 36 | 0.120 |
Why?
| | Biomedical Research | 1 | 2022 | 689 | 0.120 |
Why?
| | Lower Extremity | 1 | 2019 | 427 | 0.120 |
Why?
| | Practice Patterns, Physicians' | 1 | 2024 | 1312 | 0.120 |
Why?
| | Cell Division | 1 | 2017 | 795 | 0.120 |
Why?
| | Parenteral Nutrition | 1 | 2016 | 107 | 0.110 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 35 | 0.110 |
Why?
| | Nurseries, Hospital | 1 | 2014 | 5 | 0.110 |
Why?
| | Hydrochlorothiazide | 1 | 2014 | 9 | 0.110 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1108 | 0.110 |
Why?
| | Endocrinology | 1 | 2015 | 79 | 0.110 |
Why?
| | Homeostasis | 1 | 2018 | 622 | 0.110 |
Why?
| | Mice, Knockout | 1 | 2021 | 3020 | 0.110 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 46 | 0.110 |
Why?
| | Diuretics | 1 | 2014 | 74 | 0.110 |
Why?
| | Glucose Transporter Type 3 | 2 | 2024 | 13 | 0.110 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5792 | 0.110 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 3420 | 0.100 |
Why?
| | Animals, Inbred Strains | 1 | 2012 | 7 | 0.100 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2018 | 382 | 0.100 |
Why?
| | Mice | 5 | 2024 | 17843 | 0.100 |
Why?
| | Pregnancy, Animal | 2 | 2019 | 53 | 0.100 |
Why?
| | Pyruvic Acid | 2 | 2024 | 54 | 0.100 |
Why?
| | Cell Size | 1 | 2012 | 91 | 0.100 |
Why?
| | Electrolytes | 1 | 2012 | 59 | 0.100 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2012 | 15 | 0.100 |
Why?
| | Premature Birth | 1 | 2016 | 331 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 1 | 2016 | 555 | 0.100 |
Why?
| | Solutions | 1 | 2012 | 170 | 0.100 |
Why?
| | Macrophages | 1 | 2020 | 1548 | 0.100 |
Why?
| | Umbilical Arteries | 1 | 2012 | 54 | 0.100 |
Why?
| | Hyperplasia | 1 | 2012 | 175 | 0.100 |
Why?
| | Hernia, Diaphragmatic | 1 | 2012 | 65 | 0.090 |
Why?
| | Heart | 1 | 2016 | 660 | 0.090 |
Why?
| | Vasodilator Agents | 1 | 2014 | 333 | 0.090 |
Why?
| | Cell Aggregation | 1 | 2011 | 26 | 0.090 |
Why?
| | Models, Cardiovascular | 1 | 2013 | 195 | 0.090 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2023 | 197 | 0.090 |
Why?
| | Intestinal Obstruction | 1 | 2012 | 50 | 0.090 |
Why?
| | Mitosis | 1 | 2012 | 193 | 0.090 |
Why?
| | Infant Nutrition Disorders | 1 | 2011 | 11 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 86 | 0.090 |
Why?
| | Parenteral Nutrition, Total | 1 | 2011 | 26 | 0.090 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 267 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 5772 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 286 | 0.090 |
Why?
| | Primary Cell Culture | 1 | 2011 | 172 | 0.090 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2011 | 203 | 0.090 |
Why?
| | Animals, Newborn | 2 | 2024 | 845 | 0.090 |
Why?
| | Carbon Dioxide | 2 | 2012 | 267 | 0.090 |
Why?
| | Taurine | 1 | 2011 | 46 | 0.090 |
Why?
| | Cell Hypoxia | 1 | 2011 | 227 | 0.080 |
Why?
| | Algorithms | 3 | 2018 | 1702 | 0.080 |
Why?
| | Intensive Care, Neonatal | 1 | 2010 | 40 | 0.080 |
Why?
| | Blood Vessels | 1 | 2011 | 188 | 0.080 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2011 | 144 | 0.080 |
Why?
| | Infusions, Parenteral | 1 | 2009 | 38 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2837 | 0.080 |
Why?
| | Prevalence | 1 | 2016 | 2719 | 0.080 |
Why?
| | Gene Expression | 2 | 2011 | 1505 | 0.080 |
Why?
| | Glycine | 2 | 2023 | 175 | 0.070 |
Why?
| | Apoptosis | 2 | 2019 | 2557 | 0.070 |
Why?
| | Guidelines as Topic | 1 | 2010 | 277 | 0.070 |
Why?
| | Liver Glycogen | 1 | 2007 | 17 | 0.070 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 24 | 0.070 |
Why?
| | Insulin-Like Growth Factor Binding Protein 2 | 2 | 2020 | 8 | 0.070 |
Why?
| | Cohort Studies | 1 | 2018 | 5730 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 566 | 0.070 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1740 | 0.070 |
Why?
| | Cell Movement | 1 | 2011 | 972 | 0.070 |
Why?
| | Biological Transport | 2 | 2020 | 416 | 0.070 |
Why?
| | Cloning, Molecular | 1 | 2007 | 536 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5427 | 0.060 |
Why?
| | Lysine | 1 | 2009 | 297 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2007 | 434 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2011 | 914 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1012 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2020 | 886 | 0.060 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1770 | 0.060 |
Why?
| | Adult | 3 | 2023 | 37821 | 0.060 |
Why?
| | Citrate (si)-Synthase | 1 | 2024 | 60 | 0.050 |
Why?
| | Embryo, Mammalian | 2 | 2019 | 232 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 102 | 0.050 |
Why?
| | Risk Factors | 2 | 2016 | 10356 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2011 | 4206 | 0.050 |
Why?
| | Societies, Medical | 2 | 2020 | 820 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Elastin | 2 | 2013 | 78 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 193 | 0.050 |
Why?
| | Glycosaminoglycans | 2 | 2013 | 84 | 0.050 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2022 | 5 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 104 | 0.050 |
Why?
| | Ruminants | 1 | 2022 | 7 | 0.050 |
Why?
| | Serine | 1 | 2023 | 141 | 0.050 |
Why?
| | Glucose Transporter Type 1 | 1 | 2022 | 50 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2022 | 57 | 0.050 |
Why?
| | Birth Weight | 2 | 2018 | 516 | 0.050 |
Why?
| | Blastocyst | 1 | 2021 | 47 | 0.050 |
Why?
| | Phosphates | 1 | 2022 | 184 | 0.050 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 37 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2017 | 10821 | 0.040 |
Why?
| | Placentation | 1 | 2021 | 45 | 0.040 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 39 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2021 | 123 | 0.040 |
Why?
| | Collagen | 2 | 2013 | 447 | 0.040 |
Why?
| | Astrocytoma | 1 | 2001 | 128 | 0.040 |
Why?
| | Research Personnel | 1 | 2022 | 170 | 0.040 |
Why?
| | Weight Gain | 1 | 2023 | 518 | 0.040 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 80 | 0.040 |
Why?
| | Amino Acid Transport Systems | 1 | 2020 | 42 | 0.040 |
Why?
| | Mentors | 1 | 2022 | 197 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2017 | 2066 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 319 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 22 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 412 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 167 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2021 | 621 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 218 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 393 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 153 | 0.040 |
Why?
| | Lung | 1 | 2011 | 4066 | 0.040 |
Why?
| | Body Weight | 2 | 2012 | 973 | 0.030 |
Why?
| | Fatal Outcome | 2 | 2012 | 305 | 0.030 |
Why?
| | Temperature | 1 | 2019 | 680 | 0.030 |
Why?
| | Term Birth | 1 | 2016 | 23 | 0.030 |
Why?
| | Delphi Technique | 1 | 2018 | 273 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2008 | 474 | 0.030 |
Why?
| | Lactates | 1 | 2015 | 85 | 0.030 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2016 | 106 | 0.030 |
Why?
| | Carbon Radioisotopes | 1 | 2014 | 35 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 685 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 387 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 832 | 0.030 |
Why?
| | Blood Transfusion | 1 | 2016 | 324 | 0.030 |
Why?
| | Compliance | 1 | 2012 | 47 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2012 | 150 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2014 | 249 | 0.020 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2012 | 27 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2012 | 26 | 0.020 |
Why?
| | Acid-Base Equilibrium | 1 | 2012 | 28 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 163 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2012 | 74 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 386 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 121 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2012 | 145 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 191 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 180 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2012 | 330 | 0.020 |
Why?
| | Hormones | 1 | 2012 | 143 | 0.020 |
Why?
| | Stimulation, Chemical | 1 | 2011 | 65 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 402 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 344 | 0.020 |
Why?
| | Diseases in Twins | 1 | 2012 | 175 | 0.020 |
Why?
| | Death, Sudden, Cardiac | 1 | 2012 | 184 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 693 | 0.020 |
Why?
| | Myocardium | 1 | 2016 | 1004 | 0.020 |
Why?
| | Trans-Activators | 1 | 2012 | 399 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 26 | 0.020 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2012 | 201 | 0.020 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 21 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 44 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 27 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 62 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2012 | 316 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1679 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 504 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1580 | 0.020 |
Why?
| | Remission Induction | 1 | 2009 | 287 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 153 | 0.020 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2007 | 12 | 0.020 |
Why?
| | Child | 2 | 2020 | 22037 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4172 | 0.020 |
Why?
| | Protein Kinases | 1 | 2008 | 319 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1776 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2011 | 766 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 414 | 0.010 |
Why?
| | Body Temperature | 1 | 2005 | 221 | 0.010 |
Why?
| | United States | 1 | 2022 | 14696 | 0.010 |
Why?
| | Hypertension | 1 | 2012 | 1293 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1775 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 31 | 0.010 |
Why?
| | Rats | 1 | 2010 | 5676 | 0.010 |
Why?
| | Thoracic Vertebrae | 1 | 2001 | 78 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11097 | 0.010 |
Why?
| | Obesity | 1 | 2011 | 2974 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2001 | 3722 | 0.000 |
Why?
|
|
Rozance's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|